Michael Mina
Epidemiologist, Immunologist, Physician, Harvard Public Health/Medical School. Discuss vaccines, immunity, infectious diseases, public health
Thought Leader
| #13 | Infectious Disease |
Last synced from Twitter 79d ago
Moderna just finished recruiting 30,000 people for its coronavirus vaccine trial. One graph reveals how the biotech slowed down its research to recruit more minorities.
Minorities make up 37% of the study, but that percentage was on track to be much lower until the company slowed enrollment and closed trial sites.
Could Frequent Testing Help Squelch COVID-19?
This Medical News feature examines the debate about the value of frequent testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
6
Michael Mina
Can frequent rapid testing stop COVID-19?
I think it will... if we make them. If we had them two months ago, we could be in a very different position
A dive into the details: barriers, pitfalls and benefits by @RitaRubin
ja.ma/37sFLoX via @JAMA_current
86d
The Coronavirus Has Claimed 2.5 Million Years of Potential Life in the U.S., Study Finds
A Harvard researcher added up the number of years that Americans who died from Covid-19 might have lived had they reached a typical life expectancy.
COVID-19 Testing & The Danger of a Quick Fix Narrative
For months now, you have woken each day to a world that is both maddening and heartbreaking. You sip coffee and scroll through the day’s…
Login • Instagram
Welcome back to Instagram. Sign in to check out what your friends, family & interests have been capturing & sharing around the world.
Tedros Adhanom on why vaccine nationalism harms efforts to halt the pandemic
Going it alone will perpetuate the economic and health crisis—for all
Severe COVID-19 patients display a back boost of seasonal coronavirus-specific antibodies
Severe acquired respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of coronavirus disease (COVID-19). In severe COVID-19 cases, higher antibody titers against seasonal coronaviruses have been observed than in mild cases. To investigate...
1
Michael Mina
Severe #COVID19 resulting from Original Antigenic Sin??
May be a contributor. Makes sense
Superb paper evaluating cross-reactivity between donor B cells targeting SARS-CoV-2 and other seasonal Coronas.
This figure (2) is really depicts it well...
1/
medrxiv.org/content/10.110… pic.twitter.com/F7bFxpFvDn
87d
How the F.D.A. Stood Up to the President
After months of caving to pressures from the White House, Commissioner Stephen Hahn and a band of agency scientists have eked out a few victories.
Inner Workings: Researchers race to develop in-home testing for COVID-19, a potential game changer
For most people, COVID-19 test entails a swab up the nose in a doctor’s office or at a drive-in site. The sample then goes out to a lab. Results come back within a few days to a week—a waiting period that’s simply too long to stop the spread of the...
If only we knew the viral load
A new study shows that knowing the viral load of infected people can help chart the pandemic
All 62 residents at Kansas nursing home have COVID, 10 have died
Department of health in hard-hit Norton County, Kansas, says an unspecified number of staff at the Andbe Home also have the disease.
COVID-19 testing capacity outpacing desire to get swabbed
As covid cases surge so is the number of options to test for coronavirus infection.
What's Coming This Winter? Here's How Many More Could Die In The Pandemic
Cases are surging in many places around the country. As we head into winter here's what public health forecasters think we can expect.
COVID-19 Test Results Get Faster, But Still Too Slow To Help Slow Disease Spread
The average wait time for results of a coronavirus test has dropped to about three days, but that is still too slow to keep infected people from unknowingly spreading the virus, researchers report.
2
Michael Mina
Testing delays still far too long to help contain #COVID19:
‘The average White, Asian-American, Hispanic, or Black respondent waited 5.7, 6.1, 6.9, and 7.4 days respectively’
We need different, faster, frequent accessible rapid tests.
This can’t work
89d
A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses
Natural killer (NK) cells are heterogeneous innate effector cells, with some NK subsets displaying features of adaptive immunity including memory and antigen specificity. Because liver NK cells are enriched for adaptive NK cells, Stary et al. used...
Michael Mina
New study providing yet another link between innate and adaptive immunity. Here, honing in on memory committed natural killer cells with specificity for discrete antigens. Information that will create new opportunity for immune therapies and vaccines
89d
Around 100 Stanford faculty members condemn Hoover fellow and White House advisor Scott Atlas’ controversial views on COVID-19 | The Stanford Daily
Stanford physicians and researchers published an open letter to the Stanford University School of Medicine faculty on Wednesday that criticized Hoover Institution Senior Fellow Dr. Scott Atlas’…
More Than 1,000 Current and Former CDC Officers Condemn U.S. Covid-19 Response
An open letter expresses dismay at the nation’s public-health response to the Covid-19 pandemic and calls for the federal agency to play a more central role.
1
Michael Mina
This is fairly incredible.
At some point, enough truly becomes enough and even the muzzled begin to speak out, even if it means their careers.
Good for you @CDCgov current and former people willing to condemn the (lack of) efforts to date.
91d
A Rapid Test Offers Hope for Community Screening
In a small study in San Francisco, Abbott’s BinaxNOW identified infectious people nearly as accurately as a P.C.R. test.
21
Michael Mina
NEW! research shows rapid antigen tests can work in a real world setting - with asymptomatic and symptomatic people. The rapid "paper-strip" antigen test called the BinaxNOW detected >90% of people with high viral loads who are likely to be infectious
nytimes.com/2020/10/15/hea…
1/
91d
Can rapid antigen tests fix contact tracing in the US?
Because antigen tests are cheaper, they could be used more frequently, making it easier to spot exactly when a person becomes infectious.